Position in CYTK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$32,809,224
+$5,071,265 QoQ
Shares Held
385,130
-8.5% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#71
of 477 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. CYTK ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in CYTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,809,224 | 385,130 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $27,737,959 | 420,846 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $34,566,395 | 544,010 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $36,921,028 | 671,780 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $17,983,407 | 544,292 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $17,958,017 | 446,828 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $24,678,783 | 524,634 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $29,621,750 | 561,018 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $19,537,199 | 360,598 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $19,947,697 | 284,520 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $15,198,519 | 182,040 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,935,394 | 99,640 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,392,448 | 73,343 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,602,054 | 73,943 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,343,372 | 51,143 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,867,408 | 38,543 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,176,460 | 29,943 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,122,705 | 30,500 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $382,872 | 8,400 | Shares | Sole | 2022-02-10 | |
| 2020-09-30 | $772,905 | 35,700 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||